Article
Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors.
The international journal of neuropsychopharmacology - 1 Dec 2017
Bhakta Savita G, Light Gregory A, Talledo Jo A, Balvaneda Bryan, Hughes Erica, Alvarez Alexis, Rana Brinda K, Young Jared W, Swerdlow Neal R
Abstract excerpt
Background: Failure of procognitive drug trials in schizophrenia may reflect the clinical heterogeneity of schizophrenia, underscoring the need to identify biomarkers of treatment sensitivity. We used an experimental medicine design to test the procognitive effects of a putative procognitive agent, tolcapone, using an electroencephalogram-based cognitive control task in healthy subjects. Methods: Healthy men and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
